- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Institutional Culture and Sensitive Investigations
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News 277 results
Press Release
April 16, 2025
Economic Development and Incentives Lawyer Brendan Staley Joins King & Spalding’s Corporate Practice in Washington, D.C.
In the News
April 16, 2025
Economic Development and Incentives partner Brendan Staley joins the firm’s Corporate practice group in Washington, D.C.
Cases & Deals
Cases & Deals
März 31, 2025
King & Spalding Secures Victory for The American Clinical Laboratory Association Challenging a Final Rule Issued by the FDA
In the News
März 20, 2025
Jim Bowe discusses the impact of the 40-acre solar farm that is owned and operated by Catholic University in Washington, D.C.
Recognition
März 12, 2025
Foreign Investment Watch Names Phil Ludvigson to its Top Advisors List
In the News
In the News
Cases & Deals
Januar 30, 2025
King & Spalding Advises Phillips 66 on its $865 Million sale to ArcLight of a 25% interest in Gulf Coast Express Pipeline
In the News
Press Release
Januar 15, 2025
Lauren Roth, Former Leader of FDA’s Office of Policy, Joins King & Spalding’s FDA and Life Sciences Team